Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review

Bibliography

• Tate JE, Burton AH, Boschi-Pinto C, et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:136-41
   PubMed Web of Science ®Google Scholar
• Tate JE, Patel MM, Steele AD, et al. Global impact of rotavirus vaccines. Expert Rev Vaccines 2010;9:395-407
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rotavirus vaccines: an update. Wkly Epidemiol Rec 2009;84:533-40
   PubMedGoogle Scholar
• World Health Organization. Rotavirus vaccines. WHO position paper-January 2013. Wkly Epidemiol Rec 2013;88:49-64
   PubMedGoogle Scholar
• Forster J, Guarino A, Parez N, et al. Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics 2009;123:e393-400
   PubMed Web of Science ®Google Scholar
• Patel MM, Glass R, Desai R, et al. Fulfilling the promise of rotavirus vaccines: how far have we come since licensure? Lancet Infect Dis 2012;12:561-70
   PubMedGoogle Scholar
• Harris JP, Jit M, Cooper D, Edmunds WJ. Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease. Vaccine 2007;25:3962-70
   PubMed Web of Science ®Google Scholar
• Jit M, Edmunds WJ. Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination. Vaccine 2007;25:3971-9
   PubMed Web of Science ®Google Scholar
• Jit M, Bilcke J, Mangen MJ, et al. The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe. Vaccine 2009;27:6121-8
   PubMed Web of Science ®Google Scholar
• Jit M, Mangen MJ, Melliez H, et al. An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe". Vaccine 2010;28:7457-9
   PubMed Web of Science ®Google Scholar
• JCVI. JCVI statements on rotavirus vaccine. 2009
   Google Scholar
• JCVI. Available from: https://www.gov.uk/government/news/new-vaccine-to-help-protect-babies-against-rotavirus. 2013
   Google Scholar
• Department of Health. Important changes to the national immunisation programme in 2013-14, and introduction of rotavirus vaccination for babies at two and three months. 2013
   Google Scholar
• GreenBook. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/193107/Green_Book_Chapter_27b_v1_0W.pdf
   Google Scholar
• Vesikari T, Van Damme P, Giaquinto C, et al. European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe. J Pediatr Gastroenterol Nut 2008;46:615-18
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2009;58:1-25
   PubMedGoogle Scholar
• Dennehy PH, Brady RC, Halperin SA, et al. Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine. Pediatr Infect Dis J 2005;24:481-8
   PubMed Web of Science ®Google Scholar
• Adlhoch C, Hoehne M, Littmann M, et al. Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010 – 2011. Pediatr Infect Dis J 2013;32:e82-9
   PubMed Web of Science ®Google Scholar
• Bakare N, Menschik D, Tiernan R, et al. Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS). Vaccine 2010;28:6609-12
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Sack DA, Rothstein E, et al. Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial. Lancet 1999;354:287-90
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Korhonen T, et al. Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants. Vaccine 2004;22:2836-42
   PubMed Web of Science ®Google Scholar
• Salinas B, Perez Schael I, Linhares AC, et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J 2005;24:807-16
   PubMed Web of Science ®Google Scholar
• Phua KB, Quak SH, Lee BW, et al. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants. J Infect Dis 2005;192(Suppl 1):S6-S16
   Google Scholar
• Rivera L, Pena LM, Stainier I, et al. Horizontal transmission of a human rotavirus vaccine strain--a randomized, placebo-controlled study in twins. Vaccine 2011;29:9508-13
   PubMed Web of Science ®Google Scholar
• O'Ryan M, Lucero Y, Linhares AC. Rotarix®: vaccine performance 6 years postlicensure. Expert Rev Vaccines 2011;10:1645-59
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007;370:1757-63
   PubMed Web of Science ®Google Scholar
• Correia JB, Patel MM, Nakagomi O, et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis 2010;201:363-9
   PubMed Web of Science ®Google Scholar
• Braeckman T, Van Herck K, Meyer N, et al. Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study. BMJ 2012;345:e4752
   PubMed Web of Science ®Google Scholar
• Lopman BA, Curns AT, Yen C, Parashar UD. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis 2011;204:980-6
   PubMed Web of Science ®Google Scholar
• Glass RI. Unexpected benefits of rotavirus vaccination in the United States. J Infect Dis 2011;204:975-7
   PubMed Web of Science ®Google Scholar
• Phua KB, Lim FS, Lau YL, et al. Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: a randomized clinical trial in an Asian population. Vaccine 2012;30:4552-7
   PubMed Web of Science ®Google Scholar
• Glass RI, Parashar UD, Bresee JS, et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006;368:323-32
   PubMed Web of Science ®Google Scholar
• Patel MM, Lopez-Collada VR, Bulhoes MM, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 2011;364:2283-92
   PubMed Web of Science ®Google Scholar
• Velazquez FR, Colindres RE, Grajales C, et al. Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Pediatr Infect Dis J 2012;31:736-44
   PubMed Web of Science ®Google Scholar
• Buttery JP, Danchin MH, Lee KJ, et al. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011;29:3061-6
   PubMed Web of Science ®Google Scholar
• FDA. FDA releases final study results of a mini-sentinel postlicensure observational study of rotavirus vaccines and intussusception. 2013
   Google Scholar
• Marlow RD, Finn A. The promise of immunisation against rotavirus. Arch Dis Child 2012;97:736-40
   PubMed Web of Science ®Google Scholar
• Gay N, Ramsay M, Waight P. Rotavirus vaccination and intussusception. Lancet 1999;354:956
   PubMed Web of Science ®Google Scholar
• Samad L, Marven S, El Bashir H, et al. Prospective surveillance study of the management of intussusception in UK and Irish infants. Br J Surg 2012;99:411-15
   PubMed Web of Science ®Google Scholar
• Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010;362:299-305
   PubMed Web of Science ®Google Scholar
• Iturriza-Gomara M. unpublished data from the european surveillance programme 2013
   Google Scholar
• Iturriza-Gomara M, Dallman T, Banyai K, et al. Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network. Epidemiol Infect 2011;139:895-909
   PubMed Web of Science ®Google Scholar
• Iturriza-Gomara M, Cunliffe N. Rotavirus vaccine: a welcome addition to the immunisation schedule in the UK. BMJ 2013;346:f2347
   PubMedGoogle Scholar
• Aladin F, Nawaz S, Iturriza-Gomara M, Gray J. Identification of G8 rotavirus strains determined as G12 by rotavirus genotyping PCR: updating the current genotyping methods. J Clin Virol 2010;47:340-4
   PubMed Web of Science ®Google Scholar
• Iturriza-Gomara M, Kang G, Gray J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Virol 2004;31:259-65
   PubMed Web of Science ®Google Scholar
• Soares-Weiser K, Maclehose H, Bergman H, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev 2012;2:CD008521
   Google Scholar
• Desai R, Cortese MM, Meltzer MI, et al. Potential intussusception risk versus benefits of rotavirus vaccination in the United States. Pediatr Infect Dis J 2013;32:1-7
   Google Scholar
• Cunliffe NA, Allan C, Lowe SJ, et al. Healthcare-associated rotavirus gastroenteritis in a large paediatric hospital in the UK. J Hosp Infect 2007;67:240-4
   PubMed Web of Science ®Google Scholar
• Payne DC, Vinje J, Szilagyi PG, et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med 2013;368:1121-30
   PubMed Web of Science ®Google Scholar
• Clarke MF, Davidson GP, Gold MS, Marshall HS. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination. Vaccine 2011;29:4663-7
   PubMed Web of Science ®Google Scholar
• Zlamy M, Kofler S, Orth D, et al. The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections. BMC Infect Dis 2013;13:112
   PubMed Web of Science ®Google Scholar